Cargando…

Circulating HPV16 DNA in Blood Plasma as Prognosticator and Early Indicator of Cancer Recurrence in Radio-Chemotherapy for Anal Cancer

SIMPLE SUMMARY: Anal cancer, which is characterized by one of the highest human papillomavirus (HPV) positive case rates, is a rare disease accounting for only 0.5% of new cancer cases. Currently, there are no molecular markers for anal cancer. Circulating tumor–related HPV (ctHPV) in liquid biopsy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazurek, Agnieszka M., Małusecka, Ewa, Jabłońska, Iwona, Vydra, Natalia, Rutkowski, Tomasz W., Giglok, Monika, Suwiński, Rafał
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913251/ https://www.ncbi.nlm.nih.gov/pubmed/36765825 http://dx.doi.org/10.3390/cancers15030867

Ejemplares similares

Significance of HPV16 Viral Load Testing in Anal Cancer
por: Małusecka, Ewa, et al.
Publicado: (2020)

Quantitative analysis of plasma DNA in anal cancer patients
por: Małusecka, Ewa, et al.
Publicado: (2022)

Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis
por: Kentnowski, Marek, et al.
Publicado: (2023)

Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer
por: Rutkowski, Tomasz W., et al.
Publicado: (2020)

Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer
por: Suwinski, Rafał, et al.
Publicado: (2019)

Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet
por: Kozłowska, Emilia, et al.
Publicado: (2020)

Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy
por: Butkiewicz, Dorota, et al.
Publicado: (2021)

Comparison of Selected Immune and Hematological Parameters and Their Impact on Survival in Patients with HPV-Related and HPV-Unrelated Oropharyngeal Cancer
por: Brewczyński, Adam, et al.
Publicado: (2021)

Analysis of Selected Nutritional Parameters in Patients with HPV-Related and Non-HPV-Related Oropharyngeal Cancer before and after Radiotherapy Alone or Combined with Chemotherapy
por: Brewczyński, Adam, et al.
Publicado: (2022)

HPV status and HPV16 viral load in anal cancer and its association with clinical outcome
por: Guerendiain, Daniel, et al.
Publicado: (2022)

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection
por: Beachler, Daniel C., et al.
Publicado: (2016)

Practical Application of Circulating Tumor-Related DNA of Human Papillomavirus in Liquid Biopsy to Evaluate the Molecular Response in Patients with Oropharyngeal Cancer
por: Mazurek, Agnieszka M., et al.
Publicado: (2023)

Mapping HPV 16 Sub-Lineages in Anal Cancer and Implications for Disease Outcomes
por: Guerendiain, Daniel, et al.
Publicado: (2022)

Impact of HPV-16 Lineages Infection in Response to Radio-Chemotherapy in Cervical Cancer
por: de Figueiredo, Fábio Vidal, et al.
Publicado: (2023)

Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients
por: Zajkowicz, A, et al.
Publicado: (2015)

The Clinical Utility of Circulating HPV DNA Biomarker in Oropharyngeal, Cervical, Anal, and Skin HPV-Related Cancers: A Review
por: Andrioaie, Ioana Maria, et al.
Publicado: (2023)

Targeting HPV16 DNA using CRISPR/Cas inhibits anal cancer growth in vivo
por: Hsu, David S, et al.
Publicado: (2018)

Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status
por: Brewczyński, Adam, et al.
Publicado: (2020)

HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues
por: Stanley, Margaret A, et al.
Publicado: (2012)

The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer
por: Smolska-Ciszewska, Beata, et al.
Publicado: (2015)

Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer
por: Snietura, Miroslaw, et al.
Publicado: (2010)

The Prognostic Value of HPV Status and p16 Expression in Patients with Carcinoma of the Anal Canal
por: Roldán Urgoiti, Gloria B., et al.
Publicado: (2014)

Characterisation of anal intraepithelial neoplasia and anal cancer in HIV‐positive men by immunohistochemical markers p16, Ki‐67, HPV‐E4 and DNA methylation markers
por: van der Zee, Ramon P., et al.
Publicado: (2021)

DNA high-risk HPV, mRNA HPV and P16 tests for diagnosis of anal cancer and precursor lesions: a systematic review and meta-analysis
por: Macedo, Ana Cristina, et al.
Publicado: (2023)

Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer
por: Suwinski, Rafal
Publicado: (2021)

Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay
por: Galati, Luisa, et al.
Publicado: (2022)

Identification of Cancer-Associated Circulating Cells in Anal Cancer Patients
por: Carter, Thomas J., et al.
Publicado: (2020)

HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development
por: Elnaggar, Jacob H., et al.
Publicado: (2023)

The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results
por: Volpini, Lays Paula Bondi, et al.
Publicado: (2017)

External validation of a radiomic signature to predict p16 (HPV) status from standard CT images of anal cancer patients
por: Leijenaar, Ralph T. H., et al.
Publicado: (2023)

Distribution of HPV Genotypes in Patients with a Diagnosis of Anal Cancer in an Italian Region
por: Muresu, Narcisa, et al.
Publicado: (2020)

Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer
por: Al-Soneidar, Walid A., et al.
Publicado: (2022)

Cytosine methylation in the HPV16 3’ L1/ 5’LCR region characterized from anal epithelia of HPV-HIV coinfected men
por: Wiley, DJ, et al.
Publicado: (2010)

Correction: The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results
Publicado: (2017)

Impact of educational differences as measure of socioeconomic status on survival for breast cancer patients
por: Nowara, Elżbieta, et al.
Publicado: (2012)

p16 in HPV-associated cancers
por: Munger, Karl, et al.
Publicado: (2013)

Anal Cancer and Anal Intraepithelial Neoplasia Risk among Patients Treated for HPV-Related Gynecological Diseases—A Systematic Review
por: Brzeziński, Michał, et al.
Publicado: (2023)

Anal HIV DNA is associated with high-risk HPV genotypes in anal cytology specimens obtained for anal neoplasia screening
por: Shiramizu, Bruce, et al.
Publicado: (2012)

Episomal HPV16 responsible for aggressive and deadly metastatic anal squamous cell carcinoma evidenced in peripheral blood
por: Péré, Hélène, et al.
Publicado: (2021)

Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions
por: Lorincz, Attila T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v20623btkjhcqv014v6v0vaep9